BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 30295095)

  • 21. [Still's disease as biphasic disorder : Current knowledge on pathogenesis and novel treatment approaches].
    Föll D; Wittkowski H; Hinze C
    Z Rheumatol; 2020 Sep; 79(7):639-648. PubMed ID: 32253510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adult-onset Still's disease: Advances in the treatment.
    Castañeda S; Blanco R; González-Gay MA
    Best Pract Res Clin Rheumatol; 2016 Apr; 30(2):222-238. PubMed ID: 27886796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Adult onset Still's disease].
    Ribi C
    Rev Med Suisse; 2008 Apr; 4(154):1039-44. PubMed ID: 18557533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response rate of initial conventional treatments, disease course, and related factors of patients with adult-onset Still's disease: Data from a large multicenter cohort.
    Kalyoncu U; Solmaz D; Emmungil H; Yazici A; Kasifoglu T; Kimyon G; Balkarli A; Bes C; Ozmen M; Alibaz-Oner F; Erten S; Cagatay Y; Cetin GY; Yilmaz S; Yildiz F; Pamuk ON; Kucuksahin O; Kilic L; Yazisiz V; Karadag O; Koca SS; Hayran M; Akar S; Aksu K; Akkoc N; Keser G; Gonullu E; Kisacik B; Onat AM; Soy M; Inanc N; Direskeneli H; Sayarlioglu M; Erken E; Turgay M; Cefle A; Ertenli I; Pay S
    J Autoimmun; 2016 May; 69():59-63. PubMed ID: 26970681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated serum gasdermin D N-terminal implicates monocyte and macrophage pyroptosis in adult-onset Still's disease.
    Nagai H; Kirino Y; Nakano H; Kunishita Y; Henmi R; Szymanski AM; Yoshimi R; Ombrello MJ; Nakajima H
    Rheumatology (Oxford); 2021 Aug; 60(8):3888-3895. PubMed ID: 33550379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological agents in the management of adult-onset Still's disease.
    Girard-Guyonvarc'h C; Gabay C
    Joint Bone Spine; 2019 Jan; 86(1):5-7. PubMed ID: 29631071
    [No Abstract]   [Full Text] [Related]  

  • 27. Adult-onset Still's disease-pathogenesis, clinical manifestations, and new treatment options.
    Kadavath S; Efthimiou P
    Ann Med; 2015 Feb; 47(1):6-14. PubMed ID: 25613167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Still's disease in adults: treatment with intravenous immunoglobulins].
    Vignes S; Wechsler B
    Rev Med Interne; 1999; 20 Suppl 4():419s-422s. PubMed ID: 10522316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenesis of adult-onset Still's disease: new insights from the juvenile counterpart.
    Jamilloux Y; Gerfaud-Valentin M; Martinon F; Belot A; Henry T; Sève P
    Immunol Res; 2015 Feb; 61(1-2):53-62. PubMed ID: 25388963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of damage-associated molecular pattern for pathogenesis and biomarkers in adult-onset Still's disease.
    Jung JY; Suh CH; Kim HA
    Expert Rev Mol Diagn; 2019 Jun; 19(6):459-468. PubMed ID: 31055973
    [No Abstract]   [Full Text] [Related]  

  • 31. [Still's syndrome-similarities and differences between the juvenile and adult forms].
    Regel A; Föll D; Kriegel MA
    Z Rheumatol; 2022 Feb; 81(1):22-27. PubMed ID: 34735597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokine profile in adult-onset Still's disease: Comparison with systemic juvenile idiopathic arthritis.
    Inoue N; Shimizu M; Tsunoda S; Kawano M; Matsumura M; Yachie A
    Clin Immunol; 2016 Aug; 169():8-13. PubMed ID: 27263804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease.
    Chen DY; Lan JL; Lin FJ; Hsieh TY
    J Rheumatol; 2004 Nov; 31(11):2189-98. PubMed ID: 15517632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adult-onset Still's disease: a review.
    Owlia MB; Mehrpoor G
    Indian J Med Sci; 2009 May; 63(5):207-21. PubMed ID: 19584494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrophage activation syndrome complicating adult onset Still's disease: A single center case series and comparison with literature.
    Lenert A; Yao Q
    Semin Arthritis Rheum; 2016 Jun; 45(6):711-6. PubMed ID: 26672682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-18: a biomarker with therapeutic potential in adult-onset Still's disease.
    Chen PK; Wey SJ; Chen DY
    Expert Rev Clin Immunol; 2022 Aug; 18(8):823-833. PubMed ID: 35771972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. About the complexity of adult onset Still's disease… and advances still required for its management.
    Guilpain P; Le Quellec A
    BMC Med; 2017 Jan; 15(1):5. PubMed ID: 28056958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adult-onset Still's disease: clinical, serological and therapeutic considerations.
    Iliou C; Papagoras C; Tsifetaki N; Voulgari PV; Drosos AA
    Clin Exp Rheumatol; 2013; 31(1):47-52. PubMed ID: 23010097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac tamponade: an unusual feature of adult onset Still's disease.
    Moder KG; Miller TD; Allen GL
    J Rheumatol; 1995 Jan; 22(1):180-2. PubMed ID: 7699669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Aadult-onset Still's disease: new insights from the rheumatologists].
    Shen M; Zeng XF
    Zhonghua Yi Xue Za Zhi; 2021 Jul; 101(25):1949-1952. PubMed ID: 34225416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.